Although the pathogenesis of MS and NMO as well as the expression patterns of APQ4 and GFAP in these two diseases is quite different [2, 37], these two distinct diseases share common processes, including BBB disruption, activation of chemotactic factors, and extensive infiltration of inflammatory cells. This evidence concerns the gene GFAP and myeloid sarcoma.